Skip to content
Biodatica
Start free

Investigator

Keiichiro Kushiro

MUCOMMUNE, LLC · funded by NIDDK, NICHD, NCI

Companies
3

Resolved onto their grants.

Grants
8

Federal awards on file.

Non-dilutive funding
$5.2M

Summed across those awards.

First award
Mar 25, 2025

Latest Sep 15, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Development and evaluation of a pegloticase biobetter for sustained suppressionof fructose-induced obesity

    $360k

    Sep 15, 2025NIDDKMUCOMMUNE, LLCNIH RePORTER · 11255849 (opens the source filing in a new tab)

  2. R44

    Fast Dissolving MM008 Tablet for Instant On-Demand Non-Hormonal Contraception

    $1.1M

    Sep 15, 2025NICHDMUCOMMUNE, LLCNIH RePORTER · 11185580 (opens the source filing in a new tab)

  3. R43

    Development of MM010, a PEG-specific intervention that blocks allergic response and restores effective repeat dosing of peg-asparaginase in patients with acute lymphoblastic leukemia

    $410k

    Sep 12, 2025NCIMUCOMMUNE, LLCNIH RePORTER · 11315641 (opens the source filing in a new tab)

  4. R43

    Engineering a physiologically-tuned reservoir intravaginal ring releasing lactic acid for the treatment and prevention of bacterial vaginosis

    $310k

    Aug 21, 2025NIAIDMUCOMMUNE, LLCNIH RePORTER · 11069348 (opens the source filing in a new tab)

  5. R44

    IND-enabling development of MM-009, a reservoir-intravaginal ring for ultra-highrates of month-long lactic acid release to treat and prevent bacterial vaginosis

    $1.0M

    Jun 23, 2025NIAIDMUCOMMUNE, LLCNIH RePORTER · 11186410 (opens the source filing in a new tab)

  6. R44

    IND-enabling development of MM-009, a reservoir-intravaginal ring for ultra-highrates of month-long lactic acid release to treat and prevent bacterial vaginosis

    $993k

    Jun 23, 2025NIAIDMUCOMMUNE, LLCNIH RePORTER · 11360209 (opens the source filing in a new tab)

  7. R61

    Development of an ultrapotent anti-sperm antibody construct for non-hormonal contraception

    $381k

    Mar 25, 2025NICHDMUCOMMUNE, LLCNIH RePORTER · 11063679 (opens the source filing in a new tab)

  8. R33

    Development of an ultrapotent anti-sperm antibody construct for non-hormonal contraception

    $575k

    Mar 25, 2025NICHDMUCOMMUNE, LLCNIH RePORTER · 11478956 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources